Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
1.240
-0.070 (-5.34%)
At close: Nov 4, 2025, 4:00 PM EST
1.230
-0.010 (-0.81%)
After-hours: Nov 4, 2025, 4:55 PM EST
Tilray Brands Revenue
Tilray Brands had revenue of $209.50M in the quarter ending August 31, 2025, with 4.73% growth. This brings the company's revenue in the last twelve months to $830.77M, up 2.31% year-over-year. In the fiscal year ending May 31, 2025, Tilray Brands had annual revenue of $821.31M with 4.10% growth.
Revenue (ttm)
$830.77M
Revenue Growth
+2.31%
P/S Ratio
1.48
Revenue / Employee
$292,317
Employees
2,842
Market Cap
1.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 821.31M | 32.37M | 4.10% |
| May 31, 2024 | 788.94M | 161.82M | 25.80% |
| May 31, 2023 | 627.12M | -1.25M | -0.20% |
| May 31, 2022 | 628.37M | 115.29M | 22.47% |
| May 31, 2021 | 513.09M | 107.76M | 26.59% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
TLRY News
- 6 hours ago - Top Canadian Cannabis Stocks to Watch in November 2025 - MarijuanaStocks
- 9 hours ago - Tilray Medical Sets the Standard for Compassionate Pricing, Broadening Access to Medical Cannabis for Patients, Seniors, First Responders, and Veterans Through Expanded Pricing Programs Across Canada - GlobeNewsWire
- 3 days ago - 'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance - CNBC
- 5 days ago - Tilray Brands Sets Sights on Asia: Bringing Award-Winning Craft Beers to Japan's Premier American Craft Beer Experience Festival - GlobeNewsWire
- 12 days ago - Canadian Cannabis Leaders Poised for Growth as U.S. Legalization Momentum Builds - MarijuanaStocks
- 12 days ago - Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard Work - GlobeNewsWire
- 18 days ago - Tilray Brands Marks Seven Years of Cannabis Legalization in Canada with the #1 Market-Leading Position by Revenue and Pioneering Brands with Growing Market Share in the World's Largest Federally Legal Cannabis Market - GlobeNewsWire
- 20 days ago - Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use - Benzinga